Hot Investor Mandate: Strategic Investment Fund of Global Biopharmaceutical Seeks to Invest in Digital Health and Therapeutics Companies in Oncology & Infectious Diseases

21 Nov

A strategic fund of a large biopharmaceutical group focuses its investment strategy on oncology and infectious diseases. The fund has $150M under management and invests in the range of $1M – $10M per company. The Fund typically seeks to participate in Series A/B rounds, and is currently seeking 1-3 new equity investment opportunities a year. The fund also supports the in-licensing activities of the parent company in the EU and U.S.

The fund is mainly seeking digital health and healthcare IT investment opportunities at pre-commercial or commercial stage that will either improve drug development (e.g. patient recruitment, best responders, combination therapy) or that will impact the patient journey (e.g. patient monitoring, digital therapeutics, clinical decision support systems). In addition the firm considers therapeutic and diagnostic proposals that relate to oncology and infectious diseases. The fund is also seeking oncology and infectious disease therapeutics to in-license. The Fund is agnostic in terms of stage of development.

The fund is very active and supportive with their portfolio companies. The Fund typically seeks a board seat, and at times, also an observer seat. The Fund is looking for management teams experienced in the domain of interest and with entrepreneurial experience.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: